Lung Cancer Treatment in India

At Vanya Health, we connect domestic and international patients with India’s leading thoracic surgeons, pulmonologists, medical oncologists, and state-of-the-art cancer institutes. From keyhole video-assisted thoracic surgery (VATS) to non-invasive CyberKnife stereotactic body radiation therapy (SBRT), we facilitate access to advanced lung cancer treatment in India, helping patients receive personalized care designed to preserve lung function and optimize clinical outcomes.

Understanding
Lung Cancer

Lung cancer develops when abnormal cells lining the air passages or alveoli multiply rapidly, forming malignant tumors in pulmonary tissues. Left unmanaged, malignant cells can invade regional thoracic structures or spread metastatically through the bloodstream to distant organs such as the brain, liver, or bones.

Because early-stage lung cancer may cause subtle or non-specific symptoms, accurate anatomical staging, tissue diagnosis, and biomarker testing are important for treatment planning. At Vanya Health, thoracic oncology care is planned according to tumor stage, histology, molecular findings, lung function, and the patient’s overall condition.

Primary Classifications of Lung Cancer We Treat

Non-Small Cell Lung Cancer (NSCLC)

Represents approximately 85% of lung cancers and includes adenocarcinoma, squamous cell carcinoma, and other subtypes. Treatment may include surgery, radiation therapy, chemotherapy, targeted therapy, and/or immunotherapy depending on the stage, histology, molecular profile, PD-L1 expression, and the patient’s overall health.

Small Cell Lung Cancer (SCLC)

An aggressive, rapidly growing carcinoma strongly associated with tobacco exposure. Limited-stage disease is commonly treated with platinum-based chemotherapy and concurrent thoracic radiation, while extensive-stage disease is generally treated with systemic therapy, often including platinum-etoposide chemotherapy with immunotherapy when clinically appropriate.

Other Thoracic Malignancies

Pleural mesothelioma and pulmonary carcinoid tumors are distinct thoracic cancers rather than primary subtypes of lung cancer. Their management depends on tumor type, stage, resectability, and patient factors and may involve surgery, systemic therapy, and/or radiation.

Causes & Potential Risk Factors

While tobacco smoking remains the primary etiology, non-smoking clinical risk factors account for a significant proportion of diagnoses in India:

Tobacco & Beedi Smoking

Tobacco smoke contains multiple carcinogens that can damage DNA in respiratory cells and substantially increase lung cancer risk.

Secondhand Smoke Exposure

Exposure to secondhand tobacco smoke increases lung cancer risk in people who do not smoke.

Air Pollution & Biomass Smoke

Long-term exposure to outdoor air pollution, including particulate matter, and indoor biomass smoke is associated with increased lung cancer risk.

Occupational Carcinogens

Prolonged inhalation of asbestos fibers, radon gas, silica dust, or heavy metals (arsenic, chromium).

Genetic Predisposition

Family history and inherited genetic susceptibility may contribute to lung cancer risk in a minority of patients, including some people who have never smoked.

Symptoms & Early Warning Signs

Lung cancer symptoms vary based on tumor size, airway invasion, and distant metastatic spread:

Advanced Diagnosis & Precision Staging in India

Precise anatomical localization and molecular biomarker profiling dictate modern thoracic care plans. Vanya Health facilitates diagnostic evaluations using advanced protocols:

Why Vanya Health?

Choosing treatment abroad can feel overwhelming. Vanya Health simplifies the entire journey by helping patients connect with leading cancer specialists, accredited hospitals, and advanced treatment technologies across India. Our focus is to ensure patients receive transparent guidance, personalized treatment options, and coordinated support throughout their medical journey.

What Makes Vanya Health Different?

How Vanya Health Helps

Vanya Health acts as a trusted healthcare facilitator, helping patients navigate complex treatment decisions and connect with appropriate medical experts.

Medical Evaluation

Treatment Planning

Travel & Stay Assistance

Post-Treatment Support

Our Process

01
Share Your Medical Reports

Send MRI scans, pathology reports, surgical records, and treatment history for review.

02
Specialist Evaluation
We coordinate consultations with appropriate thoracic oncology specialists and partner hospitals.
03
Personalized Treatment Recommendations
Patients receive treatment recommendations, estimated costs, and expected timelines based on their clinical condition.
04
Travel & Treatment Coordination
Our team assists with treatment scheduling, hospital coordination, accommodation guidance, and medical visa documentation support.
05
Treatment in India
Patients receive treatment directly from their chosen hospital and specialist team.
06
Follow-Up Care
We help facilitate post-treatment communication and follow-up consultations after patients return home.

Frequently Asked Questions

Outcomes in lung cancer vary substantially according to stage, tumor biology, molecular profile, treatment received, and the patient’s overall health. Early-stage disease generally has better outcomes than advanced disease. Targeted therapies and immunotherapies have improved outcomes for selected patients with advanced NSCLC, but an individual prognosis should be discussed with the treating oncology team.

VATS and Robotic Thoracic Surgery use small keyhole incisions rather than a large thoracotomy (spreading the ribs). Compared with open thoracotomy, minimally invasive approaches such as VATS and robotic surgery can reduce postoperative pain and length of hospital stay in appropriately selected patients. Recovery time and complication risk vary according to the operation, patient health, and clinical circumstances.

Yes. A significant percentage of lung cancer patients—especially women in Asia diagnosed with EGFR-mutated Adenocarcinoma—have no history of smoking. Environmental pollution, passive smoke exposure, radon gas, and genetic factors play major roles.

For selected patients with early-stage non-small cell lung cancer who are medically inoperable or cannot safely undergo surgery, stereotactic body radiation therapy (SBRT), delivered using an appropriate radiation platform, is an established non-surgical treatment option that can provide high rates of local tumor control. SBRT also has potential treatment-related risks and requires specialist assessment.

Yes. Vanya Health can facilitate medical record review and specialist consultations, helping patients understand available treatment options before making travel arrangements.

Advanced Lung Cancer Treatment Options Offered in India

India’s thoracic oncology centers leverage modern surgical techniques and precision radiation to achieve optimal therapeutic control.

Have questions? Get in touch!